Valuation Considerations in Telehealth Transactions

Overview



Against the backdrop of COVID-19, telehealth partnerships and transactions are taking center stage in today’s dynamic market. These deals present unique valuation issues, however, they are subject to a complex array of state and federal fraud and abuse laws and corporate practice of medicine prohibitions.

In this fourth installment of our webinar series, we’ll analyze telehealth deal structures and the role of valuation firms, and review available market comparability resources to guide the valuation outcomes.

Our seasoned lawyers will discuss:

  • Services being used for telehealth and virtual care
  • Valuation needs and market trends
  • Compensation arrangements
  • Innovative collaborations and how they are affecting valuations

Access the takeaways here.
Access the slides here.

Registration information

12:00 pm – 1:00 pm ET

CLE Credit Available

Dig Deeper

Webinar / Speaking Engagements / November 18, 2021

Telehealth: Open Roads and Barriers to New Models of Health Care

Webinar / HCCA / November 8-10, 2021

HCCA's Healthcare Enforcement Compliance Conference

Webinar / Speaking Engagements / October 18, 2021

HLTH Boston 2021

Virtual Event / McDermott Event / October 15, 2021

HPE New York 2021

Webinar / Chicago Bar Association / October 8, 2021

The Biden Administration's Antitrust Priorities

Webinar / McDermott Event / October 5 - 6, 2021

DC bio future

Get In Touch